Publications by authors named "C Baiguera"
Background: (MG) is responsible for non-gonococcal urethritis. Our aim is to describe MG positivity rate and incidence in specific populations.
Methods: Retrospective, surveillance study included all samples collected from 2018 to 2022.
Oral HPV infection is the main risk factor for the development of oropharyngeal carcinoma. Men who have sex with men (MSM), especially if living with HIV (PLWH), are at increased risk of infection and consequently of cancer development. Aim of this study is to evaluate the impact of nonavalent vaccine on oral HPV infection in a cohort of MSM and transgender women (TGW).
View Article and Find Full Text PDFObjectives: In this study, we compared the performance of a self-administered point-of-care test (POCT) for anal human papillomavirus (HPV) screening with laboratory gold-standard test in pre-exposure prophylaxis (PrEP) users and evaluated its feasibility.
Methods: We enrolled PrEP users from a local community-based PrEP service. Each participant self-collected an anal swab to test anal HPV with a PCR POCT capable of detecting 14 high-risk HPV genotypes.
Article Synopsis
- Aflatoxin M1 (AFM1) is a carcinogenic compound that can contaminate milk and dairy products, prompting the EU to set limits for its concentration in milk.
- In 2019, the Italian Ministry of Health suggested four enrichment factors (EFs) for cheese based on moisture content, aiming to assess AFM1 levels in bovine dairy products.
- The study found that the average EF values were lower than those proposed by the Italian Ministry of Health, indicating that the current EFs may need to be re-evaluated for better risk assessment of AFM1 in cheese.
Article Synopsis
- HCV infection can cause immune issues beyond the liver, and co-infection with HIV amplifies this immune activation. This study focuses on how inflammatory markers and mixed cryoglobulinemia change in HIV/HCV co-infected patients after successful DAA treatment.
- The research tracked 129 patients who started DAA treatment between 2015 and 2020, measuring various inflammatory markers at multiple time points, and found notable improvements in certain markers like cryocrit and rheumatoid factor soon after treatment.
- While there was a significant decrease in mixed cryoglobulinemia positivity and some inflammatory markers improved, autoantibody reactivity remained mostly unchanged, indicating DAA therapy benefits some inflammation but not autoantibody